PharmaBoardroom

Dan Leonard – President & CEO, Association for…

Dan Leonard, president and CEO of the Association for Accessible Medicines (AAM) since August 2020, outlines his key agenda priorities as head of the…

Alejandro Mora – Country Manager Central America &…

Alejandro Mora, Ferrer’s country manager for Central America & Caribbean, discusses the complexity of the region’s healthcare systems, the…

USA: 2 Things the Biden Administration can do Now to Lower Costs…

PhRMA’s Stephen J. Ubl outlines two ways in which the new US presidency can help lower healthcare costs and why biopharmaceutical companies support…

China: AstraZeneca/Junshi anti-PD-1 Tie-Up; New UK Biologics Plan…

The latest from Chinese pharma, including a new deal between AstraZeneca and Junshi Biosciences; Innoforce and dMed’s R&D collab; and investment…

Carl Firth – CEO, ASLAN Pharmaceuticals

ASLAN Pharmaceuticals is a clinical-stage immunology-focused biopharmaceutical company. CEO Dr Carl Firth reveals why the company has shifted its…

ISREC’s Susan Gasser: A “Hard-Nosed” Approach to Research…

After 15 years as director at the Friedrich Miescher Institute for Biomedical Research (FMI) (2004-2019) and even longer as the group leader at her…

Mexico: US Vaccine Tourism; CanSino Stepping Up; AMLO Calls for…

The latest from Mexico’s fight against COVID-19, including news of vaccine tourism into the US, how China’s CanSino is filling the gaps left by…

Marc-Olivier Geinoz – CEO, Dipharma SA

Dipharma SA is a Swiss specialty pharmaceutical company, developing improved generics medicines for rare metabolic diseases. Founder & CEO…

HSA: APAC’s Regulatory Gold Standard

As the most important pharma hub in its region, and one of the most important globally, many companies look to launch new products in Singapore first…